BTG3 and melanoma: In addition to Tregs, the levels of TGF-β IL-10, and autoantibodies (ANA, ACA, anti-dsDNA, and anti-HTG) were measured in serum samples collected from 14 of the 22 patients with melanoma undergoing IFN-α 2b treatment in this study.